pISSN 1226-6051
eISSN 2508-786X

Table. 3.

Table. 3.

The usage according to efficacy for drugs that list suicide in the precautions for use

PatientsPrescriptionDay of administration

 EfficacyNN(%)N(%)N(%)
Insomnia treatment229,382(36.4%)205,010(34.5%)3,208,193(35.5%)
Epilepsy treatment1719,004(23.6%)144,512(24.3%)2,011,964(22.3%)
Antidepressant1418,474(22.9%)131,847(22.2%)1,943,242(21.5%)
Tricyclic antidepressant28,364(10.4%)71,221(12.0%)1,159,672(12.8%)
Antianxiety drugs53,947(4.9%)29,841 (5.0%)436,386(4.8%)
Antipsychotics3896(1.1%)10,133(1.7%)227,198(2.5%)
ADHD treatment2194(0.2%)686(0.1%)12,427(0.1%)
COPD treatment110(0.01%)90(0.02%)2,605(0.03%)
Smoking cessation therapy1111(0.31)746(0.1%)10,742(0.1%)
Narcolepsy treatment161(0.1%)242(0.04%)11,110(0.1%)
Gastrointestinal motility modulator213(0.02%)18(0.003%)20(0.0002%)
Antiviral agent1236(0.3%)658(0.1%)1,850(0.02%)

Total5180,692(100%)595,004(100%)9,025,409(100%)
Korean J Clin Pharm 2019;29:202-8 https://doi.org/10.24304/kjcp.2019.29.3.202
© 2019 Korean J Clin Pharm